Document is current
Any future updates will be listed below
-
Authors
Cousin, Sophie
Guégan, Jean-Philippe
Palmieri, Lola Jade
Metges, Jean Philippe
Pernot, Simon
Bellera, Carine A.
Assenat, Eric
Korakis, Iphigenie
Cassier, Philippe Alexandre https://orcid.org/0000-0003-3857-1688
Hollebecque, Antoine
Cantarel, Coralie
Kind, Michèle
Soubeyran, Isabelle
Sokol, Harry https://orcid.org/0000-0002-2914-1822
Vanhersecke, Lucile
Bessede, Alban
Italiano, Antoine https://orcid.org/0000-0002-8540-5351
-
Funding
Funding for this research was provided by:
Merck KGaA (REGOMUNE)
- License Information
-
More Information
Article History
Received: 4 April 2024
Accepted: 17 January 2025
First Online: 9 April 2025
Competing interests
: A.B. and J.P.G. are employees of Explicyte. A.I. received research grants from Astra Zeneca, Bayer, BMS, Chugai, Merck, MSD, Pharmamar, Novartis and Roche and personal fees from Epizyme, Bayer, Lilly, Roche and Springworks. W.H.F. received a research grant from AstraZeneca and personal fees from Anaveon, AstraZeneca, Catalym, Elsalys, Novartis, OSE Immunotherapeutics and Parthenon. J.Y.B. received research grants from Bayer, GSK, Merck, Novartis, Pharmamar and Roche and personal fees from Bayer, GSK, Lilly, Novartis, Pharmamar and Roche. The other authors declare no competing interests.
